<DOC>
	<DOCNO>NCT01003236</DOCNO>
	<brief_summary>There considerable evidence increase blood glucose result generation reactive oxygen specie , ultimately lead increase oxidative stress variety tissue . This may lead activation stress-sensitive intracellular signaling pathway , cause cellular damage late complication diabetes include renal injury . Although investigator understand hyperglycemia-induced oxidative stress ultimately lead tissue damage advance considerably recent year , effective therapeutic strategy prevent delay development damage remain limited . The flavonoid complex silymarin , extract milk thistle , major pharmacological active component silibinin free radical scavenger potent membrane stabilizer prevent lipid peroxidation . Furthermore , early stage diabetes , flavonoid minimize oxidative stress , inflammation represent important factor development diabetic nephropathy . In study investigator plan evaluate renoprotective effect milk thistle extract type II diabetic patient kidney disease .</brief_summary>
	<brief_title>Evaluating Renoprotective Effect Milk Thistle Extract Patients With Type II Diabetic Nephropathy</brief_title>
	<detailed_description />
	<mesh_term>Kidney Diseases</mesh_term>
	<mesh_term>Diabetic Nephropathies</mesh_term>
	<mesh_term>Silymarin</mesh_term>
	<criteria>Type II diabetes Overt proteinuria define urinary albumin excretion &gt; 300 mg/24 hr 2 consecutive determination despite treatment high FDA recommend dos angiotensin convert enzyme inhibitor angiotensin receptor blocker least 6 month . Treatment hyperglycemia ( limited ) oral hypoglycemic agent insulin ( If thiazolidinedione use , stable dose least 6 month ) Treatment hypercholesterolemia ( limit ) one medication class statins Presence diabetic retinopathy Signing inform consent Type I diabetes Advanced chronic kidney disease define estimate GFR &lt; 30 ml/min/1.73 m2 Severely uncontrolled diabetes define HbA1C &gt; 10 % Uncontrolled hypertension define SBP &gt; 160 mmHg DBP &gt; 100 mmHg despite antihypertensive therapy Secondary form hypertension define etiology diabetes mellitus Other renal disease History solid organ transplantation Chronic Heart Failure NYHA class III IV Active infection Pregnancy Use one follow medication within 2 month prior enrollment study : Nonsteroidal antiinflammatory agent Antioxidants supplement include : vitamin E , vitamin C , Nacetyl cysteine ( NAC ) , Pentoxyfilline , Lipoic acid , Fishoil extract ( omega3 fatty acid ) , Soy extract ( isoflavones ) , Greentea preparation , Pomegranate extract , Grape extract Active malignancy Hepatitis virus Human Immunodeficiency virus infection History drug alcohol dependency Cigarette smoke Psychiatric neurological condition , prevent aware consent study and/or adherence study protocol</criteria>
	<gender>All</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>June 2012</verification_date>
	<keyword>Diabetic nephropathy</keyword>
	<keyword>Type II Diabetes</keyword>
	<keyword>Milk Thistle extract</keyword>
	<keyword>Silymarin</keyword>
</DOC>